MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

25 Jun 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has attached the media release on 25th June 2021, titled ‘Glenmark Pharmaceuticals receives ANDA tentative approval for Nintedanib Capsules, 100 mg and 150 mg’ which is self?explanatory. 

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..